Skip to main content

Want a detailed portfolio tracker?

Wave Life Sciences (WVE) P/E (2015 - 2026)

Wave Life Sciences (WVE) P/E from Nov 11, 2015 to Jul 21, 2026. The TTM Wave Life Sciences (WVE) P/E is -5.37. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Wave Life Sciences (WVE)

YearP/EChange
2026-5.37-60.62%
2025-13.62-17.18%
2024-16.45+200.65%
2023-5.47+66.31%
2022-3.29+142.99%
2021-1.35-35.05%
2020-2.08+46.86%
2019-1.42-82.96%
2018-8.33-16.51%
2017-9.97-26.24%
2016-13.52+115.72%
2015-6.27N/A

Comparison Wave Life Sciences (WVE) P/E with competitors

Wave Life Sciences (WVE) P/E is -5.37.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.08%
ENLVEnlivex Ltd0.07-101.39%
FGENFibroGen Inc0.24-104.47%
CHRSCoherus Biosciences Inc0.85-115.82%
FBIOFortress Biotech Inc0.95-117.69%
ORMPOramed Pharmaceuticals Inc1.50-128.01%
AGENAgenus Inc3.01-156.09%
INVAInnoviva Inc3.15-158.79%
VXRTVaxart Inc3.55-166.16%
CRMDCorMedix Inc3.63-167.63%
CVACCureVac N.V.4.45-182.86%
GLPGGalapagos NV4.86-190.56%
SRPTSarepta Therapeutics Inc4.88-190.99%
ABEOAbeona Therapeutics Inc5.39-200.41%
ABUSArbutus Biopharma Corp5.60-204.29%
ZVRAZevra Therapeutics Inc5.89-209.73%
SPROSpero Therapeutics Inc6.23-216.09%
CGENCompugen Ltd6.31-217.68%
RIGLRigel Pharmaceuticals6.87-228.08%
SLXNSilexion Therapeutics Corp7.30-235.99%
OMEROmeros Corporation9.26-272.57%
AUPHAurinia Pharmaceuticals Inc9.58-278.65%
PLXProtalix BioTherapeutics Inc10.89-302.99%
ACADAcadia Pharmaceuticals Inc11.73-318.60%
TBPHTheravance Biopharma Inc12.26-328.54%
ADMAAdma Biologics Inc12.42-331.45%
HRMYHarmony Biosciences Holdings Inc13.82-357.58%
SABSSAB Biotherapeutics Inc14.14-363.47%
NAGENiagen Bioscience Inc14.82-376.18%
INCYIncyte Corp15.82-394.90%
REGNRegeneron Pharmaceuticals Inc15.86-395.54%
PBYIPuma Biotechnology Inc17.32-422.73%
CPRXCatalyst Pharmaceuticals Inc17.44-425.04%
EXELExelixis Inc17.54-426.88%
TGTXTG Therapeutics Inc18.97-453.49%
MDXGMimedx Group Inc20.55-483.06%
XOMAXOMA Royalty Corp22.87-526.36%
ARGXArgen X SE24.30-552.88%
CTMXCytomX Therapeutics Inc24.82-562.63%
XOMAOXOMA Royalty Corp25.34-572.40%
HALOHalozyme Therapeutics Inc25.62-577.59%
XOMAPXOMA Royalty Corp25.67-578.46%
VRTXVertex Pharmaceuticals Inc27.99-621.79%
RPRXRoyalty Pharma plc - Class A28.69-634.70%
SLNOSoleno Therapeutics Inc29.02-640.81%
ASNDAscendis Pharma A/S30.09-660.76%
LGNDLigand Pharmaceuticals Inc - Class B37.91-806.63%
APLSApellis Pharmaceuticals Inc39.02-827.31%
BMRNBiomarin Pharmaceutical Inc42.21-886.78%
KRYSKrystal Biotech Inc45.34-945.15%
ONCBeiGene Ltd69.54-1396.15%
PHARPharming Group N.V.75.03-1498.38%
TECHBio-Techne Corp101.96-2000.38%
VCELVericel Corp109.92-2148.80%
ALNYAlnylam Pharmaceuticals Inc117.96-2298.72%
GMABGenmab140.29-2714.85%
TLXTelix Pharmaceuticals Ltd162.15-3122.33%
CORTCorcept Therapeutics Inc212.86-4067.40%